Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Biotech, AI Company Partner on Covid-19 Alert System

SARS-CoV-2 particle

A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants. . . . → Read More: Biotech, AI Company Partner on Covid-19 Alert System

Sanofi Partners in $5.3B Precision Drug Discovery Deal

Chemical atom model

A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion. . . . → Read More: Sanofi Partners in $5.3B Precision Drug Discovery Deal

Optogenetics Start-Up Raises $6M for Retinal Therapy

Eye measurements

A new company developing a therapy using light-sensitive proteins for treating an inherited eye disorder is raising $6 million in seed funds. . . . → Read More: Optogenetics Start-Up Raises $6M for Retinal Therapy

Oxford, GSK Partner on New Tech for Neuro Diseases

Brain circuits illustration

GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases

Alphabet Forms AI Drug Discovery Company

Artificial intelligence graphic

Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs. . . . → Read More: Alphabet Forms AI Drug Discovery Company

Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Blooming cannibis plant

A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Psychedelic Therapy Company Raises $80M in New Funds

Psilocybe aztecorum

A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds

Alzheimer’s Digital Biomarkers Project Gains New Funds

Brain circuits illustration

A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia. . . . → Read More: Alzheimer’s Digital Biomarkers Project Gains New Funds

3-D Printed Scaffold Helps Regrow Soft Tissue

Printed tissue scaffolds

Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth. . . . → Read More: 3-D Printed Scaffold Helps Regrow Soft Tissue

GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal

Brain activity graphic

GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders. . . . → Read More: GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal